{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699995019533824.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1111/j.1523-1755.2005.09910.x"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0085253815512799?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0085253815512799?httpAccept=text/plain"}}],"dc:title":[{"@value":"Systemic and glomerular hypertension and progression of chronic renal disease: The dilemma of nephrosclerosis"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699995019533824","@type":"Researcher","foaf:name":[{"@value":"Rafael Marín"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995019533825","@type":"Researcher","foaf:name":[{"@value":"Manuel Gorostidi"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995019533826","@type":"Researcher","foaf:name":[{"@value":"Francisco Fernández-Vega"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995019533827","@type":"Researcher","foaf:name":[{"@value":"Rafael Álvarez-Navascués"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00852538"}],"prism:publicationName":[{"@value":"Kidney International"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2005-12","prism:volume":"68","prism:startingPage":"S52","prism:endingPage":"S56"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license","http://www.elsevier.com/open-access/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0085253815512799?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0085253815512799?httpAccept=text/plain"}],"createdAt":"2005-11-15","modifiedAt":"2025-09-25","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050013397240361344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Calcium channel blocker in patients with chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681274437248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Efficacy analysis of the lipid-lowering and renoprotective effects of rosuvastatin in patients with chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681425622912","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"1．高齢化社会の日本で増え続ける腎硬化症の病態と治療戦略"},{"@language":"en","@value":"1. Pathophysiology and Therapeutic Strategies of Nephrosclerosis in the Ageing Society, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/2050870367074154368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prevalence and risk factor analysis of nephrosclerosis and ischemic nephropathy in the Japanese general population"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1111/j.1523-1755.2005.09910.x"},{"@type":"CROSSREF","@value":"10.1007/s10157-013-0833-5_references_DOI_B3AIM0MN60TOH4EloCp40uIzM34"},{"@type":"CROSSREF","@value":"10.1007/s10157-021-02153-1_references_DOI_B3AIM0MN60TOH4EloCp40uIzM34"},{"@type":"CROSSREF","@value":"10.1507/endocrj.k11e-080_references_DOI_B3AIM0MN60TOH4EloCp40uIzM34"},{"@type":"CROSSREF","@value":"10.2169/naika.105.811_references_DOI_B3AIM0MN60TOH4EloCp40uIzM34"}]}